Konkurrenz
Unternehmen | Börsenwert | G | R | O | W | T | H |
---|---|---|---|---|---|---|---|
AstraZeneca PLC LSE:AZN |
185,71 Mrd. £ | 10,83 % | 5/6 | 1,37 % | -6,43 % | 13,23 % | UP |
Novo Nordisk A/S CPSE:NOVO B |
1.504,99 Mrd. kr | 21,42 % | 6/6 | 10,60 % | 55,09 % | 35,22 % | DOWN |
Merck NYSE:MRK |
211,59 Mrd. $ | 7,30 % | 6/6 | 8,86 % | 27,74 % | 18,05 % | DOWN |
Gilead Sciences NasdaqGS:GILD |
142,76 Mrd. $ | -0,44 % | 4/6 | 28,67 % | -46,81 % | 11,26 % | UP |
Pfizer NYSE:PFE |
141,46 Mrd. $ | 2,34 % | 4/6 | -0,62 % | 35,83 % | 12,54 % | DOWN |
Sanofi ENXTPA:SAN |
98,50 Mrd. € | 3,03 % | 5/6 | 8,88 % | 15,43 % | 34,33 % | DOWN |
Vertex Pharmaceuticals NasdaqGS:VRTX |
101,56 Mrd. $ | 7,41 % | 4/6 | 119,40 % | -1,70 % | 21,55 % | DOWN |
GSK LSE:GSK |
59,63 Mrd. £ | -0,73 % | 3/6 | 2,44 % | 11,63 % | 0,80 % | UP |
Regeneron Pharmaceuticals NasdaqGS:REGN |
59,45 Mrd. $ | 13,01 % | 5/6 | -7,75 % | 23,61 % | 29,06 % | DOWN |
Merck KGaA XTRA:MRK |
47,57 Mrd. € | 7,30 % | 5/6 | -1,63 % | 29,78 % | 32,54 % | DOWN |
Takeda Pharmaceutical Company TSE:4502 |
7.049,28 Mrd. ¥ | 10,31 % | 4/6 | 44,96 % | -1,88 % | 13,01 % | UP |
Daiichi Sankyo Company TSE:4568 |
6.811,47 Mrd. ¥ | 17,17 % | 4/6 | 10,08 % | 53,43 % | 52,17 % | DOWN |
Bayer XTRA:BAYN |
27,74 Mrd. € | -1,43 % | 2/6 | -4,28 % | 29,90 % | -4,39 % | UP |
Teva Pharmaceutical Industries NYSE:TEVA |
21,74 Mrd. $ | -0,24 % | 4/6 | 2,86 % | -93,46 % | 21,37 % | UP |
Astellas Pharma TSE:4503 |
3.034,58 Mrd. ¥ | -8,29 % | 3/6 | 65,81 % | 22,75 % | -2,65 % | UP |
Biogen NasdaqGS:BIIB |
20,62 Mrd. $ | -9,29 % | 1/6 | -2,32 % | 31,77 % | 13,74 % | DOWN |
Baxter International NYSE:BAX |
12,54 Mrd. $ | -6,03 % | 1/6 | 16,05 % | 50,53 % | 4,42 % | DOWN |
Viatris NasdaqGS:VTRS |
12,24 Mrd. $ | -10,47 % | 3/6 | -9,88 % | -9,28 % | 4,76 % | UP |
BioMarin Pharmaceutical NasdaqGS:BMRN |
11,09 Mrd. $ | 19,56 % | 5/6 | 18,33 % | 66,15 % | 64,45 % | DOWN |
Swedish Orphan Biovitrum AB (publ) OM:SOBI |
96,11 Mrd. kr | 4,06 % | 4/6 | 16,03 % | 6,13 % | 26,54 % | DOWN |